The global Thromboelastography Market is estimated to be valued at US$ 125.17 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:-

Thromboelastography is a test that measures the properties of clot formation and clot breakdown and lysis. It provides a graphical record of the clotting and thrombotic process which helps in understanding patients coagulation status in cases of excessive bleeding or clotting. It is utilized in surgical procedures to prevent thrombosis or bleeding complications.

Market key trends:-

One of the key trends in the thromboelastography market is the rising demand for point of care testing devices. Point of care testing is defined as medical diagnostic testing performed outside the clinical laboratory near to or at the site of the patient at the time of consultation. It provides quick results compared to conventional methods. Hence, there has been a growing demand for integrated hemostasis analysis devices which combines various coagulation assays like prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, platelet function testing and thromboelastography tests into a single platform helping clinicians in near patient testing and timely clinical decision making. Many key players are focusing on development and commercialization of portable POC TEG devices to target emergency rooms, operating rooms, and intensive care units. For instance, in 2020, Haemonetics Corporation launched TEG 6s, a next generation thromboelastography analyser specifically designe-

The thromboelastography market is segmented as Analyzers, reagents, and accessories. Among these, the analyzers segment dominated the market with a share of over 60% in 2022. This is because analyzers are the key components required to conduct thromboelastography testing. Moreover, the demand for automated analyzers is increasing owing to benefits like reduced turnaround time, ease of operation, and consistency in results.

Key Takeaways:-

The Global Thromboelastography Market Size is expected to witness high growth, exhibiting CAGR of 7.1% over the forecast period, due to increasing prevalence of cardiovascular diseases and blood-related disorders.

Regional analysis:-

North America currently dominates the thromboelastography market, owing to factors such as growing adoption of point-of-care coagulation testing devices, presence of leading players, and rising healthcare expenditure. Asia Pacific is expected to grow at the fastest rate during the forecast period due to increasing healthcare awareness and improving healthcare infrastructure in emerging economies.

Key players :-

Key players operating in the thromboelastography market are Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, Framar Hemologix srl, and Instrumentation Laboratory. Haemonetics Corporation currently leads the market owing to its strong geographical presence and wide portfolio of automated analyzers. The other key players are focusing on new product launches and regional expansion to strengthen their positions.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it